Last reviewed · How we verify
Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues
This study will evaluate hyperemia and ocular surface tolerability in patients on prostaglandin analogues
Details
| Lead sponsor | Allergan |
|---|---|
| Phase | Phase 4 |
| Status | COMPLETED |
| Enrolment | 106 |
| Start date | 2007-09 |
| Completion | 2008-09 |
Conditions
- Open Angle Glaucoma
- Ocular Hypertension
Interventions
- Bimatoprost 0.03%
- travoprost 0.004%
- latanoprost 0.005% eye drops
Primary outcomes
- Change From Baseline in Mean Conjunctival Hyperemia Scores at Month 3 — Baseline, Month 3
Change from baseline in mean conjunctival hyperemia scores at month 3. Hyperemia is engorgement of the blood vessels (redness) of the bulbar conjunctiva of the eye (the clear membrane covering the white surface of the eye). Hyperemia was graded using a 5-point scale in which 0=no redness and +3=deep, diffuse redness. A negative number change from baseline indicates improvement.
Countries
United States